D.E. Shaw & Co’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

D.E. Shaw & Co’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-991,420	Closed	-$9.8M	–	5744
2022 Q2	$9.8M	Sell	991,420 -59,992	-6%	-$592K	0.01%	1404
2022 Q1	$10.4M	Buy	1,051,412 +280,213	+36%	+$2.75M	0.01%	1564
2021 Q4	$7.56M	Buy	771,199 +173,333	+29%	+$1.71M	0.01%	1946
2021 Q3	$5.87M	Buy	597,866 +327,253	+121%	+$3.22M	0.01%	1956
2021 Q2	$2.68M	Buy	270,613 +225,876	+505%	+$2.27M	﹤0.01%	2638
2021 Q1	$459K	Buy	+44,737	New	+$497K	﹤0.01%	3544

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

D.E. Shaw & Co's LUXA Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q3 2022, closing a stake of 991,420 shares — an estimated $9.8M sold.

D.E. Shaw & Co first reported a position in LUXA in Q1 2021 and held it in 6 quarters. The position peaked at $10.4M in Q1 2022. 72 funds tracked by Wall St. Rank hold LUXA as of Q3 2022.

D.E. Shaw & Co reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
D.E. Shaw & Co sold 991,420 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $9.8M.
D.E. Shaw & Co first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
D.E. Shaw & Co's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $10.4M in Q1 2022.
72 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.